Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project

Journal of the American Pharmacists Association

Volumn 54, Issue 6, 2014, Pages 584-593

  Bacci, Jennifer L ^a   McGrath, Stephanie Harriman ^b   Pringle, Janice L ^a   Maguire, Michelle A ^c   McGivney, Melissa Somma ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Rite Aid   (United States)

^c Southeast Inc   (United States)

Author keywords

Community pharmacy; Medicare Star Ratings; Medication adherence; Medication therapy management; Pennsylvania Project; Targeted interventions

Indexed keywords

ADAPTATION; ADULT; ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; ORGANIZATIONAL STRUCTURE; PATIENT CARE; PHARMACIST; PHARMACY; PHYSICIAN; PRESCRIPTION; QUALITATIVE RESEARCH; WORKLOAD; ATTITUDE TO HEALTH; CLINICAL TRIAL; EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN RELATION; INTERPERSONAL COMMUNICATION; INTERVIEW; MEDICATION THERAPY MANAGEMENT; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PERCEPTION; PROFESSIONAL STANDARD; PROGRAM EVALUATION; PSYCHOLOGY; STANDARDS; TEACHER; UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; COMMUNITY PHARMACY SERVICES; EDUCATION, PHARMACY, CONTINUING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; MENTORS; PENNSYLVANIA; PERCEPTION; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; PROGRAM EVALUATION; QUALITATIVE RESEARCH;

EID: 84908871263     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2014.14034     Document Type: Article

References (47)

1. Nau DP. Quality and the future of health care. In: Warkholak TL, Nau DP, eds. Quality & safety in pharmacy practice. New York: McGraw-Hill Medical; 2010:3-8.
2. McBane S, Trewet CB, Havican SN, et al. Tenets for developing quality measures for ambulatory clinical pharmacy services. Pharmacotherapy. 2011;31(7):115e-134e.
3. Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General. Office of the Chief Pharmacist, U.S. Public Health Service. December 2011. http://www. usphs.gove/corpslink/pharmacy/sc-comms-sg-report.aspx. Accessed July 15, 2013.
4. Rucker NL. Medicare Part D's medication therapy management: shifting from neutral to drive. Insight on the issues, Number 64, AARP Public Policy Institute, Washington, DC, June 2012.
5. Morrison CM, Glover D, Gilchrist SM, et al. A program guide for public health: partnering with pharmacists in the prevention and control of chronic diseases. http://www.cdc.gov/dhdsp/programs/ nhdsp-program/docs/Pharmacist-Guide.pdf. Accessed June 22, 2013.
6. Patient Centered Primary Care Collaborative. The patient-centered medical home: incorporating comprehensive medication management to optimize patient outcomes. http://www.accp. com/docs/positions/misc/CMM%20Resource%20Guide.pdf. Accessed June 22, 2013.
7. Nau DP. Aligning financial incentives in quality. In: Warkholak TL, Nau DP, eds. Quality & safety in pharmacy practice. New York: McGraw-Hill Medical; 2010:229-239.
8. American Pharmacists Association, Academy of Managed Care Pharmacy. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharm Assoc. 2014; 54:228-240.
9. Pharmacy Quality Alliance. Executive update on medication quality measures in Medicare Part D star ratings. http:// www.pqaalliance.org/files/2012UpdateOnMedicarePartDStar Ratings.pdf. Accessed June 19, 2012.
10. Pharmacy Quality Alliance. PQA measures used by CMS in the star ratings. http://www.pqaalliance.org/images/uploads/ files/2013%20Update%20on%20Medicare%20Plan%20Ratings. pdf. Accessed June 2, 2013.
11. Inland Empire Health Plan. Pay for performance (P4P) program. https://ww3.iehp.org/en/providers/pharmaceutical-services/ pharmacy-p4p-program. Accessed October 13, 2014.
12. American Pharmacists Association. DOTxMED: pharmacistdelivered interventions to improve care for patients with diabetes. J Am Pharm Assoc. 2012;52:25-33.
13. Brennan TA, Dollar TJ, Hu M, et al. An integrated pharmacybased program improved medication prescription and adherence rates in diabetes patients. Health Affairs. 2012;31(1):120-129.
14. Touchette DR, Rao S, Dhru P, et al. Identification of and intervention to address therapeutic gaps in care. Am J Manag Care. 2012;18(10):e364-e371.
15. Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009;49(1):51-58.
16. Dunlop JA, Shaw JP. Community pharmacists' perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24:224-230.
17. Osborne MA, Snyder ME, Hall DL, et al. Evaluating Pennsylvania pharmacists' provision of community-based patient care services to develop a statewide practice network. Innovations. 2011;2:1-9.
18. Nadaira N, Ouellet C, René-Henri N, et al. Factors influencing a community pharmacist's interventions in asthma care. Can Pharm J. 2009;142:240-246.
19. Pharmacy Quality Alliance. PQA Mission. http://www.pqaalliance. org/. June 19, 2012.
20. Nau DP. Measuring pharmacy quality. J Am Pharm Assoc. 2009;49:154-163.
21. Doucette WR, Conklin M, Mott DA, et al. Pharmacy Quality Alliance: five phase I demonstration projects: descriptions and lessons learned. J Am Pharm Assoc. 2011;51:544-550.
22. Fitzgerald N, McCaig D, Watson H, et al. Development, implementation and evaluation of a pilot project to deliver interventions on alcohol issues in community pharmacies. Int J Pharm Pract. 2008;16:17-22.
23. Sheridan J, Wheeler A, Chen LJ, et al. Screening and brief interventions for alcohol: attitudes, knowledge and experience of community pharmacists in Auckland, New Zealand. Drug Alcohol Rev. 2008;27:380-387.
24. Pringle JL, Boyer A, Conklin MH. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff. 2014;33(8):1444-1452 .
25. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc. 2007;47:620-628.
26. Possidente CJ, Bucci KK, McClain WJ. Motivational interviewing: a tool to improve medication adherence? Am J Health-Syst Pharm. 2005;62:1311-1314.
27. Rabin BA, Brownson RC, Haire-Joshu D, et al. A glossary for dissemination and implementation research in health. J Public Health Manag Pract. 2008;14:117-123.
28. Dearing JW. Evolution of diffusion and dissemination theory. J Public Health Manag Pract. 2008;14:99-108.
29. Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.
30. Berkel C, Mauricio AM, Schoenfelder E, Sandler IN. Putting the pieces together: an integrated model of program implementation. Prev Sci. 2011;12:23-33.
31. Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18:59-82.
32. Curry LA, Nembhard IM, Bardley EH. Qualitative and mixed methods provide unique contribution to outcomes research. Circulation. 2009;119:1442-1452.
33. Kahlke RM. Generic qualitative approaches: pitfalls and benefits of methodological mixology. Int J Qual Meth. 2014;13:37-52.
34. Krueger R. Focus groups: a practical guide for applied research. Thousand Oaks, CA: Sage Publications; 2000.
35. Garcia GM, Snyder ME, McGrath SH, et al. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc. 2009;49:611-616.
36. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2012;288:1594-1602.
37. Jones JM. Record 64% rate honest, ethics of members of congress low. http://www.gallup.com/poll/151460/record-rate-honesty- ethics-members-congress-low.aspx. Accessed October 13, 2014.
38. Fitzgerald N, Watson H, McCaig D, Stewart D. Developing and evaluating training for community pharmacists to deliver interventions on alcohol issues. Pharm World Sci. 2009;31:149-153.
39. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496-502.
40. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004;(1):CD003698.
41. Dhital R, Whittlesea CM, Milligan P, et al. The impact of training and delivering alcohol brief interventions on the knowledge and attitudes of community pharmacies: a before and after study. Drug Alcohol Rev. 2013;32:147-156.
42. Roberts AS, Benrimoj SI, Chen TF, et al. Practice change in community pharmacy: quantification of facilitators. Pharmacotherapy. 2008;42:861-868.
43. Duncan-Hewitt W, Austin Z. Pharmacy schools as experts of practice? A proposal to radically restructure pharmacy education to optimize learning. Am J Pharm Educ. 2005;69(3):Article 54.
44. Kozminski M, Busby R, McGivney MS, et al. Pharmacist integration into the medical home: qualitative analysis. J Am Pharm Assoc. 2011;51(2):173-183.
45. Goldman J, Meuser J, Rogers J, et al. Interprofessional collaboration in family heath teams: an Ontario based study. Can Fam Physicians. 2010;56:e368-e374.
46. Gonzalvo J, Schmelz A, Hudmon KS. Community pharmacist and technician communication with Spanish-speaking patients: needs assessment. J Am Pharm Assoc. 2012;52:363-366.
47. Centers for Disease Control and Prevention. Select features of state pharmacist collaborative practice laws. State law fact sheet. http://www.cdc.gov/dhdsp/pubs/docs/Pharmacist-State- Law.PDF. Accessed October 13, 2014.